BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 28866609)

  • 1. Estimation of the global burden of mesothelioma deaths from incomplete national mortality data.
    Odgerel CO; Takahashi K; Sorahan T; Driscoll T; Fitzmaurice C; Yoko-O M; Sawanyawisuth K; Furuya S; Tanaka F; Horie S; Zandwijk NV; Takala J
    Occup Environ Med; 2017 Dec; 74(12):851-858. PubMed ID: 28866609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global trends in mortality from malignant mesothelioma: Analysis of WHO mortality database (1994-2013).
    Abdel-Rahman O
    Clin Respir J; 2018 Jun; 12(6):2090-2100. PubMed ID: 29424961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asbestos: use, bans and disease burden in Europe.
    Kameda T; Takahashi K; Kim R; Jiang Y; Movahed M; Park EK; Rantanen J
    Bull World Health Organ; 2014 Nov; 92(11):790-7. PubMed ID: 25378740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008.
    Delgermaa V; Takahashi K; Park EK; Le GV; Hara T; Sorahan T
    Bull World Health Organ; 2011 Oct; 89(10):716-24, 724A-724C. PubMed ID: 22084509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asbestos Consumption and Malignant Mesothelioma Mortality Trends in the Major User Countries.
    Gariazzo C; Gasparrini A; Marinaccio A
    Ann Glob Health; 2023; 89(1):11. PubMed ID: 36819965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of Mesothelioma Deaths by National Income Category: Current Status and Future Implications.
    Chimed-Ochir O; Arachi D; Driscoll T; Lin RT; Takala J; Takahashi K
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32967259
    [No Abstract]   [Full Text] [Related]  

  • 7. Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 Occupational Carcinogens Collaborators
    Occup Environ Med; 2020 Mar; 77(3):151-159. PubMed ID: 32054819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesothelioma risk and environmental exposure to asbestos: past and future trends in Japan.
    Azuma K; Uchiyama I; Chiba Y; Okumura J
    Int J Occup Environ Health; 2009; 15(2):166-72. PubMed ID: 19496483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictions of Mortality from Pleural Mesothelioma in Italy After the Ban of Asbestos Use.
    Oddone E; Bollon J; Nava CR; Bugani M; Consonni D; Marinaccio A; Magnani C; Barone-Adesi F
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31963601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent mortality from pleural mesothelioma, historical patterns of asbestos use, and adoption of bans: a global assessment.
    Nishikawa K; Takahashi K; Karjalainen A; Wen CP; Furuya S; Hoshuyama T; Todoroki M; Kiyomoto Y; Wilson D; Higashi T; Ohtaki M; Pan G; Wagner G
    Environ Health Perspect; 2008 Dec; 116(12):1675-80. PubMed ID: 19079719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the asbestos-related lung cancer burden from mesothelioma mortality.
    McCormack V; Peto J; Byrnes G; Straif K; Boffetta P
    Br J Cancer; 2012 Jan; 106(3):575-84. PubMed ID: 22233924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Past and current asbestos exposure and future mesothelioma risks in Britain: The Inhaled Particles Study (TIPS).
    Gilham C; Rake C; Hodgson J; Darnton A; Burdett G; Peto Wild J; Newton M; Nicholson AG; Davidson L; Shires M; Treasure T; Peto J;
    Int J Epidemiol; 2018 Dec; 47(6):1745-1756. PubMed ID: 29534192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projection of asbestos related diseases in the United States, 1985-2009. I. Cancer.
    Lilienfeld DE; Mandel JS; Coin P; Schuman LM
    Br J Ind Med; 1988 May; 45(5):283-91. PubMed ID: 3378008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal mesothelioma mortality in Italy: Spatial analysis and search for asbestos exposure sources.
    Zona A; Fazzo L; Minelli G; De Santis M; Bruno C; Conti S; Comba P
    Cancer Epidemiol; 2019 Jun; 60():162-167. PubMed ID: 31030080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occupational burden of asbestos-related cancer in Argentina, Brazil, Colombia, and Mexico.
    Pasetto R; Terracini B; Marsili D; Comba P
    Ann Glob Health; 2014; 80(4):263-8. PubMed ID: 25459327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asbestos in Belgium: an underestimated health risk. The evolution of mesothelioma mortality rates (1969-2009).
    Van den Borre L; Deboosere P
    Int J Occup Environ Health; 2014; 20(2):134-40. PubMed ID: 24999848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global magnitude and temporal trend of mesothelioma burden along with the contribution of occupational asbestos exposure in 204 countries and territories from 1990 to 2019: Results from the Global Burden of Disease Study 2019.
    Han Y; Zhang T; Chen H; Yang X
    Crit Rev Oncol Hematol; 2022 Nov; 179():103821. PubMed ID: 36165817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asbestos use and asbestos-related diseases in Asia: past, present and future.
    LE GV; Takahashi K; Park EK; Delgermaa V; Oak C; Qureshi AM; Aljunid SM
    Respirology; 2011 Jul; 16(5):767-75. PubMed ID: 21449920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The next mesothelioma wave: mortality trends and forecast to 2030 in Brazil.
    Algranti E; Saito CA; Carneiro AP; Moreira B; Mendonça EM; Bussacos MA
    Cancer Epidemiol; 2015 Oct; 39(5):687-92. PubMed ID: 26320384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asbestos related diseases from environmental exposure to crocidolite in Da-yao, China. I. Review of exposure and epidemiological data.
    Luo S; Liu X; Mu S; Tsai SP; Wen CP
    Occup Environ Med; 2003 Jan; 60(1):35-41; discussion 41-2. PubMed ID: 12499455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.